Rhelion Life Sciences Corp. (CSE: RHEL, FSE: 4YX, OTCQB: TRUFF) announced that its wholly owned subsidiary, Filament Health Corp., has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE